SCHEMBL893507

SCHEMBL893507

CCOCc1nc2c(N)nc3cc(-c4cncc(CO)c4)ccc3c2n1CC1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 19/20 0.50
TLR8 Q9NR97 13/20 0.46
NUDT1 P36639 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753818 0.90 TLR7 (0.49) TLR7TLR8
SCHEMBL3871138 0.85 TLR7 (0.65) TLR7TLR8NUDT1
SCHEMBL3861920 0.84 TLR7 (0.67) TLR7TLR8NUDT1
SCHEMBL892607 0.83 TLR7 (0.47) TLR7TLR8NUDT1
SCHEMBL30346145 0.83 TLR7 (0.47) TLR7TLR8NUDT1
SCHEMBL3863588 0.80 TLR7 (0.42) TLR7TLR8NUDT1
SCHEMBL1753807 0.80 TLR7 (0.38) TLR7TLR8
SCHEMBL3863590 0.80 TLR7 (0.42) TLR7TLR8NUDT1
SCHEMBL3861260 0.79 TLR7 (0.69) TLR7TLR8NUDT1
SCHEMBL13645732 0.79 TLR7 (0.53) TLR7TLR8NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250152703-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2025-05-15 US disclosed
US-12201684-B2 Compositions for stimulation of mammalian innate immune resistance to pathogens THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-01-21 US disclosed
US-20240417738-A1 IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER OHIO STATE INNOVATION FOUNDATION 2024-12-19 US disclosed
EP-4419112-A1 IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER Ohio State Innovation Foundation (US) 2024-08-28 EP disclosed
CN-118475357-A Immunotherapy for the treatment of cancer 俄亥俄州创新基金会 2024-08-09 CN disclosed
CN-110234401-B Methods and compositions for adaptive immunomodulation 德克萨斯大学系统董事会 2024-03-01 CN disclosed
US-20240033348-A1 METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION Pulmotect, Inc. 2024-02-01 US disclosed
US-11826422-B2 Methods and compositions for adaptive immune modulation BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-11-28 US disclosed
WO-2023070132-A1 IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER OHIO STATE INNOVATION FOUNDATION (US) 2023-04-27 WO disclosed
US-20200345842-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2020-11-05 US disclosed
US-20190269773-A1 METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2019-09-05 US disclosed
WO-2018087699-A2 METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2018-05-17 WO disclosed
US-20170072052-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2017-03-16 US disclosed
US-9504742-B2 Compositions for stimulation of mammalian innate immune resistance to pathogens THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-11-29 US disclosed
US-20160074508-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2016-03-17 US disclosed
US-9186400-B2 Compositions for stimulation of mammalian innate immune resistance to pathogens THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-11-17 US disclosed
US-20150125492-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2015-05-07 US disclosed
EP-2411521-B1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS UNIV TEXAS (US) 2015-01-14 EP disclosed
US-8883174-B2 Compositions for stimulation of mammalian innate immune resistance to pathogens THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-11-11 US disclosed
US-20120082700-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2012-04-05 US disclosed